Radiopharmaceutical 123I-joflupan

Summary

The contract concerns ongoing supplies of the radiopharmaceutical 123I-joflupan, with an activity of at least 185 MBq 123I per unit on the calibration day, for four years according to the contracting authority's needs. The radiopharmaceutical must have a valid registration with SÚKL for the Czech Republic. Electronic invoicing or an electronic process is required.